Xinran Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xinran Zhang has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Jiangbo Wei
Department of Chemistry, The University of Chicago, Chicago, USA
17 shared publications - Ang Li
Department of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
16 shared publications - Bo Liu
Department of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
16 shared publications - Cheng-Wei Ju
Department of Chemistry, The University of Chicago, Chicago, USA
16 shared publications - Han Li
The University of Chicago 2 Department of Chemistry Chicago, Illinois
16 shared publications - Helen He Zhu
State Key Laboratory of Systems Medicine for Cancer, Department of Urology, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China
16 shared publications
Latest Publications
- 2 July 2026
- Published by Oxford University Press (OUP) in The Plant Cell
- Vol. 38 (7)
Dynamic epigenetic and transcriptional regulatory network in pepper fruit development and ripening
Pepper (Capsicum) is among the most widely cultivated and consumed vegetable crops worldwide. Although studies in model fruit crops such as tomato have provided insights into the genetic and epigenetic regulation of fruit development and ripening, comparable knowledge in pepper remains limited. Here, we employ a multiomics approach to investigate transcriptome and epigenome dynamics during pepper fruit pericarp development and ripening. Our analyses reveal coordinated changes in epigenetic modifications accompanying transcriptome reprogramming. Changes in H3K27ac are closely associated with chromatin accessibility dynamics, and H3K27me3 dynamics may contribute to the transition from fruit growth to ripening. Construction of a transcriptional regulatory network suggests that several ripening regulators identified in climacteric tomato may also play critical roles in governing ripening in nonclimacteric pepper. During ripening, DNA methylation, particularly in the CG and CHG contexts, undergoes global demethylation, especially at promoter regions, accompanied by increased chromatin accessibility and likely enhances transcription factor binding. Such global demethylation resembles that observed in tomato, suggesting a potentially conserved regulatory mechanism during fruit development within the Solanaceae family. Furthermore, comparative analyses between pepper and tomato reveal conserved epigenetic regulation of key ripening-associated transcription factors, alongside distinct regulation of ethylene biosynthesis. We also demonstrate transcriptional and epigenetic regulation of carotenoid and vitamin C biosynthesis pathways in pepper. Collectively, this study provides a comprehensive resource for mechanistic dissection and comparative analysis of pepper fruit development and ripening, with potential applications for crop improvement. To facilitate data exploration, the datasets have been integrated into an online browser at http://pepperfruitatlas.org.
- 2 July 2026
- Published by Oxford University Press (OUP) in The Plant Cell
- Vol. 38 (7)
Dynamic epigenetic and transcriptional regulatory network in pepper fruit development and ripening
Pepper (Capsicum) is among the most widely cultivated and consumed vegetable crops worldwide. Although studies in model fruit crops such as tomato have provided insights into the genetic and epigenetic regulation of fruit development and ripening, comparable knowledge in pepper remains limited. Here, we employ a multiomics approach to investigate transcriptome and epigenome dynamics during pepper fruit pericarp development and ripening. Our analyses reveal coordinated changes in epigenetic modifications accompanying transcriptome reprogramming. Changes in H3K27ac are closely associated with chromatin accessibility dynamics, and H3K27me3 dynamics may contribute to the transition from fruit growth to ripening. Construction of a transcriptional regulatory network suggests that several ripening regulators identified in climacteric tomato may also play critical roles in governing ripening in nonclimacteric pepper. During ripening, DNA methylation, particularly in the CG and CHG contexts, undergoes global demethylation, especially at promoter regions, accompanied by increased chromatin accessibility and likely enhances transcription factor binding. Such global demethylation resembles that observed in tomato, suggesting a potentially conserved regulatory mechanism during fruit development within the Solanaceae family. Furthermore, comparative analyses between pepper and tomato reveal conserved epigenetic regulation of key ripening-associated transcription factors, alongside distinct regulation of ethylene biosynthesis. We also demonstrate transcriptional and epigenetic regulation of carotenoid and vitamin C biosynthesis pathways in pepper. Collectively, this study provides a comprehensive resource for mechanistic dissection and comparative analysis of pepper fruit development and ripening, with potential applications for crop improvement. To facilitate data exploration, the datasets have been integrated into an online browser at http://pepperfruitatlas.org.
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Transcriptomic and functional effects of DDC and SLC6A4 overexpression in prostate cancer cells.
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Transcriptomic and functional effects of DDC and SLC6A4 overexpression in prostate cancer cells.
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Supplementary Table Oligonucleotides
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Supplementary Table Oligonucleotides
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Data from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Neuroendocrine prostate cancer (NEPC) is an aggressive, therapy-resistant subtype of prostate cancer characterized by lineage plasticity. Although metabolic and signaling molecules are increasingly recognized as modulators of tumor progression, their role in cell fate transition remains unclear. NE (neuroendocrine) tumors produce and accumulate serotonin, a neurotransmitter that regulates diverse physiologic processes. In this study, we identify a tumor-intrinsic serotonin axis as a key driver of NEPC lineage commitment and progression. NEPC endogenously synthesizes serotonin via aromatic L-amino acid decarboxylase (AADC; encoded by DDC) and reuptakes it through the transporter SLC6A4. Mechanistically, high levels of intracellular serotonin promote histone serotonylation at H3K4me3Q5, reconfiguring the H3K4me3 chromatin landscape and downstream gene expression, which drives NE differentiation and is associated with suppressed androgen receptor signaling. Pharmacologic inhibition of serotonin synthesis using the FDA-approved DDC inhibitor carbidopa significantly impairs tumor growth and prolongs survival in both genetically engineered and patient-derived xenograft models, highlighting histone serotonylation as a druggable vulnerability in NEPC.Significance:Collectively, our findings uncover an epigenetically embedded, serotonin-driven lineage program in NEPC, coupling tumor-intrinsic serotonin metabolism with tumor cell fate control, and identify histone serotonylation as a tractable therapeutic vulnerability in lineage-plastic prostate cancer.
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Neuroendocrine prostate cancer (NEPC) is an aggressive, therapy-resistant subtype of prostate cancer characterized by lineage plasticity. Although metabolic and signaling molecules are increasingly recognized as modulators of tumor progression, their role in cell fate transition remains unclear. NE (neuroendocrine) tumors produce and accumulate serotonin, a neurotransmitter that regulates diverse physiologic processes. In this study, we identify a tumor-intrinsic serotonin axis as a key driver of NEPC lineage commitment and progression. NEPC endogenously synthesizes serotonin via aromatic L-amino acid decarboxylase (AADC; encoded by DDC) and reuptakes it through the transporter SLC6A4. Mechanistically, high levels of intracellular serotonin promote histone serotonylation at H3K4me3Q5, reconfiguring the H3K4me3 chromatin landscape and downstream gene expression, which drives NE differentiation and is associated with suppressed androgen receptor signaling. Pharmacologic inhibition of serotonin synthesis using the FDA-approved DDC inhibitor carbidopa significantly impairs tumor growth and prolongs survival in both genetically engineered and patient-derived xenograft models, highlighting histone serotonylation as a druggable vulnerability in NEPC.Significance:Collectively, our findings uncover an epigenetically embedded, serotonin-driven lineage program in NEPC, coupling tumor-intrinsic serotonin metabolism with tumor cell fate control, and identify histone serotonylation as a tractable therapeutic vulnerability in lineage-plastic prostate cancer.
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Serotonin-associated genes and pathways are enriched in NEPC.
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Serotonin-associated genes and pathways are enriched in NEPC.
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
AR blockade induces DDC upregulation and serotonin-dependent neuroendocrine lineage reprogramming.
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
AR blockade induces DDC upregulation and serotonin-dependent neuroendocrine lineage reprogramming.
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Supplementary Table. List of antibodies and small molecules used in this project
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Supplementary Table. List of antibodies and small molecules used in this project
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S11 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Transcriptomic stratification of prostate cancer patient cohorts reveals serotonin-axis activation in NE⁺ tumors.
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S11 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Transcriptomic stratification of prostate cancer patient cohorts reveals serotonin-axis activation in NE⁺ tumors.
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Supplementary Table S3. 5-HT pathway drugs in high-throughput drug screening
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Supplementary Table S3. 5-HT pathway drugs in high-throughput drug screening
- Open Access
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Serotonylation-dependent chromatin remodeling coordinates SOX9, EZH2, and ASCL1 regulatory networks in NEPC.
- 1 April 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming
Serotonylation-dependent chromatin remodeling coordinates SOX9, EZH2, and ASCL1 regulatory networks in NEPC.